1. Charles Horton writes: The existing research into ivermectin doesn’t generally strike me as very strong, with much of it showing up in non-peer-reviewed journals, or having other major flaws (i.e., the Hill study presents itself as a meta-analysis but of the 18 trials it collects, it only claims that two are high-quality—then analyzes all …